Glenmark Pharmaceuticals reports marginal rise in Q2 consolidated net profit

12 Nov 2022 Evaluate

Glenmark Pharmaceuticals reported results for second quarter ended September 30, 2022.

The company has reported 43.90% fall in its net profit at Rs 423.15 crore for Q2FY23 as compared to Rs 754.26 crore for the corresponding quarter previous year. However, total income of the company increased by 11.65% to Rs 2,524.94 crore for the quarter under review as compared to Rs 2,261.56 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported marginal rise of 1.41% in its net profit at Rs 278.67 crore for the quarter under review as compared to Rs 274.81 crore for the same quarter in the previous year. Total income of the company increased by 10.79% to Rs 3,472.68 crore for the quarter under review as compared to Rs 3,134.38 crore for the same quarter in the previous year.

Glenmark Pharma Share Price

1970.75 -25.15 (-1.26%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×